<DOC>
	<DOC>NCT02178839</DOC>
	<brief_summary>The Objective of This Study is Evaluating the Effect of oral β- glucan Supplement on Anthropometric Measurements, Appetite, Insulin Resistance, Liver echogenicity and Enzymes in Non Alcoholic Fatty Liver Patients Treating with Hypocaloric Diet and Vitamin E.</brief_summary>
	<brief_title>The Effect of Oral β- Glucan Supplement on Appetite and Insulin Resistance in Non Alcoholic Fatty Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Patients with Non Alcoholic Fatty Liver Disease From Both Sex Age 1855 years BMI more than 25 Kg/m2 Alcohol Consumption Pregnancy or lactation or menopause Being a professional athlete A history of cancer Risk of high blood pressure (in the case of drug use) Heart disease cardiovascular, pulmonary, renal and diabetes Liver transplantation and other chronic or acute Liver diseases such as hepatitis B, C and liver infections The History of inherited disorders affecting the liver A history of autoimmune disease History of food allergies Taking certain medications such as blood pressure control, statins, insulin sensitivity enhancers and hepatotoxic drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Non Alcoholic Fatty Liver Disease(NAFLD)</keyword>
	<keyword>β- glucan</keyword>
	<keyword>Appetite</keyword>
	<keyword>Insulin Resistance</keyword>
</DOC>